News – Page 78 – Endpoints News

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

6 months ago

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

6 months ago

Novo Nordisk petitions FDA to stop semaglutide compounding over safety risks

6 months ago

GSK offers glimpse at RSV vaccine in at-risk younger adults before ACIP meeting

6 months ago

Exclusive: Moldova clears first gene editing study for HBV in humans

6 months ago

Adults 50 and up should get pneumococcal vaccine, CDC advisors say, in boost to Pfizer and Merck

6 months ago

Pfizer wins approval to expand RSV vaccine to adults at higher infection risk

6 months ago

Novo Nordisk asks FDA to prohibit semaglutide compounding, following Eli Lilly

6 months ago

Allowing Novo-Catalent deal to close would be ‘wrong decision’ by antitrust authorities, Roche CEO says

6 months ago

Thermo Fisher predicts revenue uptick in 2025 as it expects headwinds to ease

6 months ago

Eccogene gets $60M from AstraZeneca; Evotec also records milestone with BMS

6 months ago

Alto Neuroscience's mid-stage trial misses primary endpoint in depression

6 months ago

Radiopharma startups stay hot as Alpha-9 bags $175M Series C

6 months ago

Life sciences investor Dimension seeks to raise $500M second fund

6 months ago

Houston startup March Biosciences raises $28M to get CAR-T into Phase 2

6 months ago

UK’s price watchdog says Lilly’s Alzheimer’s drug is too costly for broad uptake

6 months ago

Merck pays $30M to buy ‘chameleon’ approach to deadly brain cancers

6 months ago

Roche says it is undeterred by upcoming biosimilar threat to Vabysmo

6 months ago

Corrected: Sangamo to seek accelerated approval for Fabry gene therapy, claims it won't need confirmatory study

6 months ago

Eye drop maker to merge with a retinal gene therapy startup from Spark co-founder

6 months ago

Senators question whether Pfizer, Eli Lilly telehealth platforms violate law

6 months ago

Be Bio raises $82M to fund work on B cell therapy in hemophilia B

6 months ago

Amgen preps to launch Eylea biosimilar years early after Regeneron loses appeal

6 months ago

Starboard's Kenvue complaints are much different than those aimed at Pfizer

6 months ago

First page Previous page 75 76 777879 80 81 Next page Last page